pharmaceutical investing Adamas Announces Publication of Data Demonstrating Dyskinesia’s Impact on Activities of Daily Living in People with Parkinson’s Disease
Silver47 and Summa Silver Announce Closing of $6.9 Million Brokered Financing, Including Full Exercise of the Over-Allotment Option
Hempalta Issues Open Call for Strategic Partnerships to Scale Alberta-Based Nature-Based Carbon Program
